- Home
- » Tags
- » Brivaracetam
Top View
- Product Monograph-Brivaracetam
- Novel Antiepileptic Drugs
- Efficacy, Safety, and Tolerability of Brivaracetam with Concomitant
- Medicaid List of Covered Drugs (Formulary)
- Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, Effective January 20, 2021)
- Antiepileptics – Levetiracetam, Brivaracetam
- California 3 Tier with Specialty Drug List
- Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: a Practical Guide for the Intensivist
- Briviact, INN-Brivaracetam
- Scheduling Actions - Chronological Order
- Neonatal Seizures
- Effect of Brivaracetam on Efficacy and Tolerability in Patients with Brain
- New Medicines Committee Briefing May 2016 Brivaracetam (Briviact®) for Treatment of Partial Onset Seizures with Or Without Secondary Generalisation Epilepsy
- Tenncare Attestation List September 1, 2021
- New Drug Evaluation Monograph Template
- 205836Orig1s000 205837Orig1s000 205838Orig1s000
- List of Scheduling Actions, Controlled Substances And
- California 3 Tier Drug List
- Annex I Summary of Product Characteristics
- Briviact, INN-Brivaracetam
- Safety Profile of the Newest Antiepileptic Drugs: a Curated Literature Review
- BRIVIACT® Safely and Effectively
- SECTION 10. Tennessee Code Annotated, Section 39-17-452(A), Is Amended by Adding the Following As a New Subdivision (A)(3)
- Anticonvulsants
- Briviact) Reference Number: CP.PCH.26 Effective Date: 05.21.19 Last Review Date: 08.20 Coding Implications Line of Business: Commercial, HIM Revision Log
- Response of Spike-Wave Discharges in Aged APP/PS1 Alzheimer Model
- Sills, G. J. and Rogawski, M. A. (2020) Mechanisms of Action of Currently Used Antiseizure Drugs
- Senate Substitute for HOUSE BILL No. 2262
- Keppra Vimpat Brivaracetam
- Introduced 13
- Brivaracetam
- Drugs of Abuse, a DEA Resource Guide (2020 Edition)
- Continuing Education for Pharmacists Volume XXXV, No
- “New Aeds: Do They Solve DRE (Drug Resistant Epilepsy)?”
- BRIVIACT® (Brivaracetam) Tablets, for Oral Use, CV Sufficient Experience on BRIVIACT
- The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability
- Randomized Phase 2 Study of Adjunctive Cenobamate in Patients with Uncontrolled Focal Seizures
- The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications
- Clinical Review Steven Dinsmore DO Snda 205836 , 205837, 205838 Brivaracetam, BRIVIACT
- List of Covered Drugs
- Preferred Drug List (PDL)
- The Epilepsy Research Benchmarks Progress Report
- Pharmacokinetic Interaction of Brivaracetam on Other Antiepileptic
- Emerging List Dec Copy
- Characterization in Rodent Seizure and Epilepsy Models